Stephanie Milner, MBA
About Stephanie Milner, MBA
Stephanie Milner, MBA, is a Territory Manager at Novocure in the Tampa/Orlando area with over 15 years of experience in oncology sales and management.
Title
Stephanie Milner currently holds the position of Territory Manager at Novocure, focusing on the Tampa/Orlando area. In this role, she is responsible for managing territorial operations, building client relationships, and driving sales growth within the region.
Professional Experience at Bayer
Stephanie Milner worked as an Oncology Specialty Consultant at Bayer from 2015 to 2018. During this time, she played a significant role in the oncology sector, contributing to the company's growth. Her responsibilities involved promoting oncology products, collaborating with healthcare professionals, and ensuring optimal product implementation.
Professional Experience at Caris Life Sciences
From 2011 to 2015, Stephanie Milner served as the Sales Director, Oncology at Caris Life Sciences. In this role, she led a team focusing on innovative oncology diagnostics. Her leadership and strategic planning were crucial in advancing the company's oncology initiatives and expanding market reach.
Education and Expertise
Stephanie Milner holds an MBA in Business Administration from Mercer University - Stetson School of Business and Economics, achieved in 2007. She also earned a Bachelor of Business Administration (BBA) from Stetson University in 2000. Additionally, she studied business courses at Dallas College and University of Nebraska-Lincoln. Her educational background provides a strong foundation for her extensive experience in oncology sales and management.
Extensive Oncology Sales Experience
With over 15 years of experience in oncology sales and management, Stephanie Milner has a proven track record of increasing sales and market share. Her roles have included positions at Genoptix, Sepracor, and Pedinol, where she managed sales territories, launched new products, and built strong client relationships. Her broad perspective on the healthcare industry is enhanced by her experience with both pharmaceutical and biotechnology companies.